1. Introduction {#sec1}
===============

Combinatorial biosynthesis helps to enrich the novelty and diversity of the natural product architectures, offer an environmentally friendly way to produce natural product analogs, and increase the titer of the compound, eventually resulting in less expensive drugs.^[@ref1]−[@ref3]^ Enzymes are used in biocatalytic processes for the efficient and sustainable production of pharmaceuticals, fragrances, fine chemicals, and other products.^[@ref4]^ Combinatorial enzymatic synthesis is a green and efficient synthesis strategy compared with traditional chemical synthesis. Combined with the utilization of non-natural substrates and the nonspecificity of enzymes, enzymatic synthesis achieves further evolution and ascension in combinatorial chemistry.^[@ref5],[@ref6]^

Polyketide synthases (PKSs) are an important class of biologically active and structurally diverse secondary metabolites in nature. Polyketides are synthesized through decarboxylative condensation of two-carbon acetate units by PKSs.^[@ref7]−[@ref11]^ According to their sequences, primary structures, and catalytic mechanisms, PKSs fall into three groups: type I PKS, type II PKS, and type III PKS.^[@ref12]−[@ref17]^ Type III PKS catalyzes sequential decarboxylative condensations of malonyl-CoA with an aromatic or aliphatic CoA-linked starter molecule without using the acyl carrier protein to produce a variety of biologically active secondary metabolites.^[@ref18],[@ref19]^ Despite their structural simplicity, type III PKS produces a wide array of compounds such as chalcones, pyrones, acridones, phloroglucinols, stilbenes, and resorcinolic lipids.^[@ref20],[@ref21]^

Recently, CsyB from *Aspergillus oryzae* is a unique type III PKS that is involved in the biosynthesis of short-chain product csypyrone B1. This is the first type III PKS that performs not only the polyketide chain elongation by decarboxylative condensation but also the condensation of two β-ketoacyl units by non-decarboxylative condensation ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}). Interestingly, a fatty acyl CoA binding tunnel of a length of about 16 Å is located in its active center, so it is a very likely hypothesis that more diversified start units, in particular, a number of precursors of unnatural long-chain fatty acyl diketide-NAC, would be accepted to form the novel non-natural products by in vitro enzyme assays. Due to this, the I375F mutant of CsyB can accept the C~4~--C~9~ fatty acyl diketide-NAC substrates to synthesize the unnatural novel product, while the wild type only accepts the C~4~--C~7~ fatty acyl diketide-NAC substrates.^[@ref22]^ Therefore, for testing this hypothesis, the catalytic capability and substrate diversity of the I375F mutant of CsyB were evaluated for synthesis of the non-natural long-chain β-branch pyrones in this paper.

![Catalytic reaction of CsyB.](ao9b02473_0006){#fig1}

2. Results and Discussion {#sec2}
=========================

2.1. Expression and Purification of CsyB {#sec2.1}
----------------------------------------

The recombinant CsyB was expressed in *Escherichia coli* as a fusion soluble protein with a His6-tag at the C terminus and purified to homogeneity by a combination of Ni-affinity chromatography. The purified His6-tag-fused CsyB protein migrated as a single band with a molecular mass of 45 kDa on SDS-PAGE, which agrees well with the calculated value of 45.2 kDa ([Figure S1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b02473/suppl_file/ao9b02473_si_001.pdf)).

2.2. Synthesis of Different Length Diketide SNACs {#sec2.2}
-------------------------------------------------

For examination of the substrate selectivity of CsyB for fatty acyl diketide-NACs with various lengths, short-chain (C~4~ to C~10~) and long-chain (C~16~ to C~18~) diketide-NACs were synthesized according to the published method^[@ref22]^ ([Scheme S1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b02473/suppl_file/ao9b02473_si_001.pdf)). The synthetic C~16~ and C~18~ diketide-NAC compounds were isolated, purified, and identified on a small scale. Based on the high-resolution liquid chromatography--mass spectrometry (HRLC--MS) and nuclear magnetic resonance (NMR) data, C~16~ and C~18~ diketide-NACs had a molecular formula of C~22~H~41~NO~3~S at *m*/*z* 400.2819 \[M + H\]^+^ (calcd for C~22~H~41~NO~3~S, 400.2807) and 428.3102 \[M + H\]^+^ (calcd for C~24~H~45~NO~3~S, 428.3120), respectively, and data of ^1^H and ^13^C NMR also were in accordance with their structures ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}) ([Figures S2--S7](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b02473/suppl_file/ao9b02473_si_001.pdf)).

![Substrates of diketide-NACs.](ao9b02473_0002){#fig2}

2.3. Enzymatic Synthesis of Unnatural Long-Chain β-Branch Pyrones Using C~16~ Diketide-NAC {#sec2.3}
------------------------------------------------------------------------------------------

The CsyB-specific fatty acyl CoA binding tunnel is highly similar to long-chain pyrone enzymes such as ORAS in *Neurospora crassa* and PKS18 in *Mycobacterium tuberculosis*.^[@ref23],[@ref24]^ It is suggested that this enzyme may also be able to accept a series of long-chain substrates such as ORAS and PKS18, although its native substrates are short-chain. To test this hypothesis, we performed the enzyme reactions using various lengths of diketide-NAC thioesters as substrates. The in vitro enzyme assay was carried out as previously described.

To check the substrate diversity and tolerance, C~16~ diketide-NAC and several short-chain diketide-NACs from C~4~ to C~9~ diketide-NACs were used to synthesize the non-natural long-chain β-branch pyrones by the purified CsyB mutant enzyme I375F by high-performance liquid chromatography (HPLC) in vitro. The CsyB I375F catalyzed the coupling reaction between one molecule of a short-chain (C~4~--C~9~) diketide-NAC and one molecule of long-chain C~16~ diketide-NAC to yield the six new products **1**--**6** with various lengths of acyl chains ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}).

![HPLC results of CsyB I375F with long-chain C~16~ diketide-NAC.](ao9b02473_0005){#fig3}

The HPLC result showed that six new peaks were detected at 310 nm, which stood for specific absorption of β-branch pyrones. Furthermore, for confirming the molecular weights (MWs) of new compounds, these new peaks were measured by HRLC--MS. The result showed that compound **1** had a molecular formula of C~24~H~40~O~4~ at *m*/*z* 393.2941 \[M + H\]^+^ (calcd for ~24~H~40~O~4~, 393.2927). Similarly, the molecular formulas and *m*/*z* of other five compounds **2**--**6** are summarized in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}.

###### Molecular Weights of Csypyrone Derivatives

   no.      formula      calcd MW   MW
  ----- ---------------- ---------- ----------
    1    C~24~H~40~O~4~  392.2927   392.2941
    2    C~25~H~42~O~4~  406.3083   406.3067
    3    C~26~H~44~O~5~  420.3240   420.3256
    4    C~27~H~46~O~5~  434.3396   434.3379
    5    C~28~H~48~O~5~  448.3553   448.3541
    6    C~29~H~50~O~4~  462.3709   462.3723
    7    C~26~H~44~O~5~  420.3240   420.3226
    8    C~27~H~46~O~5~  434.3396   434.3408
    9    C~28~H~48~O~5~  448.3553   448.3571
   10    C~29~H~50~O~4~  462.3709   462.3724
   11    C~30~H~52~O~5~  476.3866   476.3882
   12    C~31~H~54~O~5~  490.4022   490.4001

2.4. Enzymatic Synthesis of Unnatural β-Branch Pyrones Using C~18~ Diketide-NAC {#sec2.4}
-------------------------------------------------------------------------------

For further testing of the substrate diversity and tolerance, C~18~ diketide-NAC and several short-chain diketide-NAC from C~4~ to C~9~ diketide-NACs were used to synthesize the non-natural long-chain β-branch pyrones by the purified CsyB mutant enzyme I375F in vitro. The CsyB I375F using one molecule of a short-chain (C~4~--C~9~) diketide-NAC and one molecule of long-chain C~18~ diketide-NAC catalyzes coupling reactions to yield the six products **7**--**12** with various lengths of acyl chains ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}). Furthermore, for confirming the MWs of new compounds, these new peaks were measured by HRLC--MS. The result showed that compound **7** had a molecular formula of C~26~H~44~O~5~ at *m*/*z* 420.3240 \[M + H\]^+^ (calcd for C~26~H~44~O~5~, 420.3226). Similarly, molecular formulas and *m*/*z* of other five compounds **8**--**12** are summarized in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}.

![HPLC results of CsyB I375F with long-chain C~18~ diketide-NAC.](ao9b02473_0003){#fig4}

2.5. Kinetics Parameter Comparison between Short-Chain and Long-Chain Diketide-NAC {#sec2.5}
----------------------------------------------------------------------------------

The steady-state kinetics values of the CsyB I375F mutants for C~4~--C~6~ diketide-NAC substrates are summarized in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"} according to previous work. The kinetics parameters for the reactions of C~16~--C~18~ diketide-NAC substrates were also determined with the substrate C~5~ diketide-NAC. Steady-state kinetics parameters were determined from the Lineweaver--Burk plot method ([Figures S8--S12](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b02473/suppl_file/ao9b02473_si_001.pdf)).

###### Steady-State Kinetics Parameters of CsyB I375F[a](#t2fn1){ref-type="table-fn"}

  substrate            *K*~m~ (mM)   *k*~cat~ (min^--1^)   *k*~cat~/*K*~m~ (s^--1^ M^--1^)
  -------------------- ------------- --------------------- ---------------------------------
  C~4~ diketide-NAC    7.1 ± 2.6     37.2 ± 11.1           87.5
  C~5~ diketide-NAC    1.4 ± 0.6     8.7 ± 2.5             92.9
  C~6~ diketide-NAC    4.5 ± 1.6     32.9 ± 5.4            122.2
  C~16~ diketide-NAC   5.4 ± 1.8     42.8 ± 4.5            132.1
  C~18~ diketide-NAC   6.5 ± 2.1     52.9 ± 8.4            135.6

Data are presented as mean value of three experiments ±SD.

The steady-state kinetics values of CsyB I375F for long-chain diketide-NACs were a little better than those of short-chain diketide-NACs. In addition, C~18~ diketide-NAC has a bit stronger affinity than C~16~ diketide-NAC to enzyme in the long-chain diketide-NACs. Furthermore, the kinetics parameters for different substrates reported in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"} show that *k*~cat~ instead of *K*~m~ is the major parameter to be affected, while one would expect that varying the carbon chain length of the substrate should mainly affect substrate binding instead of chemical catalysis. The reason is quite likely related to the catalytic mechanism of this KS class. Because CsyB and other type III PKSs such as ORAS and PKS18 accept the various lengths of fatty acyl-CoAs (or SNACs, a kind of CoA analog) by binding the CoA or SNAC group as well as the fatty acyl group as shown in [Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}. Therefore, these enzymes exhibit the extensive substrate specificity for fatty acyl diketide-NACs with various lengths, short chain (C~4~ to C~10~) and long chain (C~16~ to C~18~).

![Crystal structure of wild-type CsyB binding with CoA.](ao9b02473_0004){#fig5}

3. Conclusions {#sec3}
==============

CsyB, a novel fungal type III polyketide synthase, can sequentially accept one molecular of short-chain fatty acyl CoA as a start unit, one molecular of malonyl-CoA, and one molecular of acetoacetyl-CoA as an extend unit to produce the short-chain csypyrone B1--B3 in natural conditions. Because a fatty acyl CoA binding tunnel of 16 Å length is located in its active center, more diversified start units are proposed to be accepted by CsyB. In order to attempt to synthesize the long-chain β-branch pyrone, an in vitro enzyme assay was done using a number of precursors of unnatural fatty acyl SNAC using CsyB. The results of HPLC revealed that a series of long-chain csypyrone derivatives were detected. These 12 new long-chain β-branch pyrone compounds were preliminarily analyzed by UV--visible spectroscopy and HRLC--MS. By comparing the enzymatic kinetics parameters of the long- and short-chain substrates, it was found that the enzyme could not only utilize the long-chain substrates but also show better affinity to the long-chain substrates than to the short-chain substrates These results demonstrate that CsyB exhibits a remarkable ability to synthesize non-natural products and broad specificity for long-chain fatty acyl SNAC. The application of CsyB in combinatorial chemistry was realized, which laid a foundation for its industrial application.

4. Experimental Section {#sec4}
=======================

4.1. Materials {#sec4.1}
--------------

Coenzyme A (CoA), fatty acyl-CoA, acetoacetyl-CoA, malonyl-CoA, and SNAC were obtained from Sigma-Aldrich. Acyl diketide-NACs with various lengths were synthesized according to the published methods.^[@ref25],[@ref26]^ Oligonucleotides were obtained from Sangon Biotech (Shanghai) Co., Ltd. The expression vector pET-CsyB was stored at a −80 °C freezer in our laboratory.

4.2. Synthesis of the Various Alkyl Diketide-NACs {#sec4.2}
-------------------------------------------------

The synthesis scheme of alkyl diketide-NAC is shown as follows. Various fatty acids were used to synthesize the alkyl diketide-NACs. There are two steps in this reaction. First, fatty acid reacted with Meldrum's acid at room temperature for 4 h in CH~2~C~l2~ along with dicyclohexylcarbodiimide (DCC) and dimethylaminopyridine (DMAP). After purifying the intermediate, the second step was performed at 80 °C for 5 h in toluene. Then the targeted compound was isolated from the final product using silica gel. The eight unnatural alkyl diketide-NAC substrates were synthesized using the above method.

4.3. Expression and Purification of CsyB {#sec4.3}
----------------------------------------

The pET-CsyB/*E. coli* BLR (DE3) strain was incubated to an OD~600~ of 0.6 at 37 °C in an LB medium containing 50 mg mL^--1^ kanamycin. The target protein expression was induced at 20 °C overnight by adding the isopropyl [d]{.smallcaps}-1-thiogalactopyranoside (IPTG) to a final concentration of 0.6 mM. The *E. coli* cells were harvested by centrifugation at 7000*g* for 15 min. The cells were suspended and disrupted by ultrasonication, and the lysate was centrifuged at 10000*g* for 30 min. After protein was purified by metal affinity chromatography, gel filtration chromatography was used as the last step on a HiLoad 16/60 Superdex 200 pg (GE Healthcare). All of the procedures were performed at 4 °C.

4.4. Enzyme Assay and Kinetics Parameters of CsyB and Mutants {#sec4.4}
-------------------------------------------------------------

The enzyme assay was performed, and the kinetics parameters were measured as previously reported.^[@ref22]^ Different chain lengths of diketide-NACs and the purified enzyme were preincubated at 37 °C for 5 min, and then the reactions were initiated by adding the purified enzyme and then further incubated at 37 °C for 20 min. The decreased amount of substrate was quantified by HPLC analysis. Steady-state kinetics parameters were determined from the Lineweaver--Burk plots.

The Supporting Information is available free of charge at [https://pubs.acs.org/doi/10.1021/acsomega.9b02473](https://pubs.acs.org/doi/10.1021/acsomega.9b02473?goto=supporting-info).SDS-PAGE of purified CsyB I375F, synthetic scheme of alkyl diketide-NACs, and ^1^H and ^13^C NMR spectra of C~4~ to C~9~ diketide-NACs ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b02473/suppl_file/ao9b02473_si_001.pdf))
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